Buy, Sell or Hold: Barr Laboratories (BRL-N) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Barr Laboratories (BRL-N)

0.00

0.00 (0.00%) 1d

PAST TOP PICK

(A Top Pick Sept 26/05. Down 7%.) Still likes. Down because the Wal-Mart announcement of putting price pressures on generics. Very innovative company, introducing lots of new products. Acquiring a European company to increase penetration into Europe.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Sept 26/05. Up 10%.) Still likes and is continuing to buy it here. The big news is the approval of their oral contraceptive.

biotechnology / pharmaceutical

BUY

Has come off sharply but she is still buying. There were delays in the FDA in getting some of its drugs approved. Earnings will continue to be delivered and thinks their drug will be approved. Good value.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Mar 15/06. Down 22%.) Lowered its guidance by $0.01 and also received a letter from the FDA denying them an extension on a patent. Feels they can continue to grow earnings in the 15/20% range. In a good buying range now.

biotechnology / pharmaceutical

TOP PICK

Generic drug manufacturer. Earnings are growing in the 20/25% range. Generics are the beneficiaries of the push to control the accelerating healthcare costs in the US. Have a good record of acquiring new generics and delivering them in a very cost effective way. No debt on the balance sheet. Great operating margins in the 35/38% range.

biotechnology / pharmaceutical

TOP PICK

Barr Pharma is a generic manufacturer. Good match with a large cap drug company. Barr is a very good company. Strong balance sheet. Started buying at $47-48 range and are still buying.

biotechnology / pharmaceutical

TOP PICK

A generic manufacturer, so unlike big pharmas that suffer when things come off, they actually benefit. Just picked up Allegra which is coming off patent. A great growth vehicle with a lot of drugs coming off patent in the next several years. Great exposure in women's health products.

biotechnology / pharmaceutical

BUY

Prefers the US health care stocks as they are much larger and much more seasoned. The big pharma has been a very difficult area. A generic manufacturer. As more and more drugs come off patent, this is a good way to take advantage of the increasing demand for drugs.

biotechnology / pharmaceutical

TOP PICK

A generic drug manufacturer. Going to continue to grow at 15/20% over the next 3/5 years. There's a number of drugs coming off patent over the next 2/3 years and this company is probably the best positioned to benefit. Good price.

biotechnology / pharmaceutical

BUY ON WEAKNESS

Generic drugs is a great sector. Accumulate on a gradual basis.

biotechnology / pharmaceutical

DON'T BUY

Health sector has been under a lot of pressure. Prefers specialty pharmaceuticals.

biotechnology / pharmaceutical

Showing 1 to 11 of 11 entries

«
‹
1
›
»

Barr Laboratories(BRL-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Barr Laboratories is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Barr Laboratories(BRL-N) Frequently Asked Questions

What is Barr Laboratories stock symbol?

Barr Laboratories is a OTC stock, trading under the symbol BRL-N on the (). It is usually referred to as or BRL-N

Is Barr Laboratories a buy or a sell?

In the last year, there was no coverage of Barr Laboratories published on Stockchase.

Is Barr Laboratories a good investment or a top pick?

Barr Laboratories was recommended as a Top Pick by on . Read the latest stock experts ratings for Barr Laboratories.

Why is Barr Laboratories stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Barr Laboratories worth watching?

0 stock analysts on Stockchase covered Barr Laboratories In the last year. It is a trending stock that is worth watching.

What is Barr Laboratories stock price?

On , Barr Laboratories (BRL-N) stock closed at a price of $.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.